/Companies

Torramics

2 known investors

Find your way into Torramics

102 people in our graph share verified history with the Torramics team — schools, employers, funds. One of them is your warm intro.

Torramics is developing an ultra-small disposable insulin patch pump ("nanoPump") that combines nanofluidic technology with a nanoCompressor to deliver three days of insulin in a compact form factor. The device targets people living with insulin-dependent diabetes.

Founders & leadership

PGPeter Garbuz
Peter GarbuzCo-founder & CEO
DJDavid Johnston
David JohnstonCo-founder, ProductDavid Johnston has over 25 years of experience managing product development and commercialization of pharmaceutical, biological, nutritional and medical device products, including building and integrating organizational capabilities and managing strategic planning and business development initiatives.
SGSergey Gimelshein
Sergey GimelsheinCo-founder, PhysicsSergey Gimelshein is a computational fluid dynamics specialist with over 30 years of experience in code and model development, validation, and multi-dimensional flow modeling. He has contributed to multiple open-source and institutional CFD and kinetic simulation tools, and has published extensively in rarefied gas dynamics and plasma interactions.
JCJulya Collins
Julya CollinsFounder

Investors · 2

Frequently asked questions

What does Torramics do?
Torramics is developing an ultra-small disposable insulin patch pump ("nanoPump") that combines nanofluidic technology with a nanoCompressor to deliver three days of insulin in a compact form factor. The device targets people living with insulin-dependent diabetes.
Who founded Torramics?
Torramics was founded by Peter Garbuz, David Johnston, Sergey Gimelshein, Julya Collins.
Who are Torramics's investors?
Torramics's investors include Aurum Venture Partners, VU Venture Partners.